Nebula is free while in beta — browse the evidence map with no account.Open Nebula →
AEaH.aiEvidence · Intelligence

trial · primary record

Semaglutide 3 mg

Obesity

PhasePhase 3
StatusCOMPLETED
SponsorUnknown
Enrolment70
Primary completion2025-04-09
Primary endpointPercentage Weight Change
Registry IDNCT05073835

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T02:32:14.992Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT05073835

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Start monitoring — $199/monthAll trial records
Semaglutide 3 mg — trial | AEaH